Literature DB >> 26406918

Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance.

Josep Puig1,2, Gerard Blasco1, Josep Daunis-i-Estadella2, María Moreno3, Xavier Molina1, Angel Alberich-Bayarri4, Gemma Xifra3, Salvador Pedraza1, Wifredo Ricart3, Fernando Fernández-Aranda5, José Manuel Fernández-Real3.   

Abstract

OBJECTIVE: Rodent models have found that osteocalcin crosses the blood-brain barrier and regulates behaviour. No data are available on osteocalcin's effects on brain microstructure and cognitive performance in humans. We evaluated the association between serum osteocalcin concentrations and (i) brain microstructural changes on magnetic resonance imaging (MRI) and (ii) neuropsychological performance. DESIGN, PATIENTS AND MEASUREMENTS: We studied 24 consecutive obese subjects (13 women; age, 49·8 ± 8·1 years; body mass index [BMI], 43·9 ± 4·54 kg/m(2) ) and 20 healthy volunteers (10 women; age, 48·8 ± 9·5 years; BMI, 24·3 ± 3·54 kg/m(2) ) in a cross-sectional study within the multicentre FLORINASH Project. FLAIR signal intensity and DTI-metrics (primary (λ1 ), secondary (λ2 ) and tertiary (λ3 ) eigenvalues; fractional anisotropy (FA); and mean diffusivity) in the caudate, hypothalamus, thalamus and putamen, and in subcortical white matter were assessed. Cognitive performance evaluated by neuropsychological test battery.
RESULTS: Lower osteocalcin concentrations were associated with BMI, higher λ1, λ2 and λ3 values at the caudate and lower FLAIR signal intensity at the caudate and putamen. Obese patients with lower osteocalcin concentrations had higher FA at putamen and thalamus. Lower osteocalcin concentrations were associated with higher Iowa Gambling Task (IGT) scores. FLAIR signal intensity at the caudate <601·832 yielded 85·7% sensitivity, 64·3% specificity, 70·6% negative predictive value and 81·8% positive predictive value for IGT score. Lower osteocalcin was an independent predictor of worse cognitive performance on multivariate analysis (F = 3·551, P = 0·01343; R(2) = 0·103). Bayesian information criterion demonstrated that osteocalcin had the predominant role in predicting IGT score.
CONCLUSIONS: Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26406918     DOI: 10.1111/cen.12954

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  18 in total

Review 1.  Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2018-02-10       Impact factor: 3.843

2.  Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns.

Authors:  Ryan D Ross; Raj C Shah; Sue Leurgans; Teodoro Bottiglieri; Robert S Wilson; Dale Rick Sumner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-11-10       Impact factor: 6.053

3.  Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial.

Authors:  Monica Castle; Nancy Fiedler; Lilliana Claudia Pop; Stephen J Schneider; Yvette Schlussel; Deeptha Sukumar; Lihong Hao; Sue A Shapses
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

4.  Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.

Authors:  Ryan D Ross; Arnold Z Olali; Qiuhu Shi; Donald R Hoover; Anjali Sharma; Kathleen M Weber; Audrey L French; Heather McKay; Phyllis C Tien; Michael T Yin; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

Review 5.  Osteocalcin in the brain: from embryonic development to age-related decline in cognition.

Authors:  Arnaud Obri; Lori Khrimian; Gerard Karsenty; Franck Oury
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

6.  Improving brain age estimates with deep learning leads to identification of novel genetic factors associated with brain aging.

Authors:  Kaida Ning; Ben A Duffy; Meredith Franklin; Will Matloff; Lu Zhao; Nibal Arzouni; Fengzhu Sun; Arthur W Toga
Journal:  Neurobiol Aging       Date:  2021-04-20       Impact factor: 5.133

Review 7.  Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders.

Authors:  Hongzhen Chen; Dewei Shang; Yuguan Wen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-06-10

8.  Association between osteocalcin and cognitive performance in healthy older adults.

Authors:  Steven Bradburn; Jamie S McPhee; Liam Bagley; Sarianna Sipila; Lauri Stenroth; Marco Vincenzo Narici; Mati Pääsuke; Helena Gapeyeva; Gabrielle Osborne; Lorraine Sassano; Carel G M Meskers; Andrea B Maier; Jean-Yves Hogrel; Yoann Barnouin; Gillian Butler-Browne; Chris Murgatroyd
Journal:  Age Ageing       Date:  2016-08-11       Impact factor: 10.668

9.  Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment.

Authors:  Peng-Ying Gu; Feng Yu; Song Jin; Qian Yang; Jing Su; Yan Chen; Liang Zhao; Shi-Lian Hu
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

Review 10.  Osteocalcin-A Versatile Bone-Derived Hormone.

Authors:  Sarah C Moser; Bram C J van der Eerden
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.